Skip to main content

Lacerations

1
Pipeline Programs
3
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Innovation Pharmaceuticals
1 program
1
LET LidocainePhase 41 trial
Active Trials
NCT04203225Completed48Est. Nov 2019
Temple Therapeutics
Temple TherapeuticsNetherlands - Geleen
2 programs
Absorbable Suture ArmN/A1 trial
Arm 2: Absorbable suturesN/A1 trial
Active Trials
NCT00933829Withdrawn0Est. Sep 2010
NCT00681070Completed74Est. Sep 2010
KitoTech Medical
KitoTech MedicalWA - Seattle
1 program
microMendN/A1 trial
Active Trials
NCT03830515Unknown30Est. Dec 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Innovation PharmaceuticalsLET Lidocaine
KitoTech MedicalmicroMend
Temple TherapeuticsAbsorbable Suture Arm
Temple TherapeuticsArm 2: Absorbable sutures

Clinical Trials (4)

Total enrollment: 152 patients across 4 trials

NCT04203225Innovation PharmaceuticalsLET Lidocaine

Comparison of Two Application Techniques for LET Gel

Start: May 2017Est. completion: Nov 201948 patients
Phase 4Completed
NCT03830515KitoTech MedicalmicroMend

Evaluation of microMend Device to Close Lacerations

Start: Apr 2018Est. completion: Dec 201930 patients
N/AUnknown
NCT00933829Temple TherapeuticsAbsorbable Suture Arm

Comparison of Cosmetic Outcomes of Lacerations Repaired Using Absorbable Versus Non-absorbable Sutures

Start: Apr 2009Est. completion: Sep 20100
N/AWithdrawn
NCT00681070Temple TherapeuticsArm 2: Absorbable sutures

Cosmetic Outcomes of Absorbable Versus Non-absorbable Sutures in Pediatric Facial Lacerations

Start: Apr 2008Est. completion: Sep 201074 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.